Financing

Noncontrolling interest transactions and other

AbbVie Noncontrolling interest transactions and other decreased by 94.6% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 97.0%, from $67.00M to $2.00M.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026May 8, 2026
Metric ID: lin_noncontrolling_interest_transactions_and_other

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q1 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q3 '25Q1 '26
Value$5.00M$21.00M$2.00M$21.00M$5.00M$15.00M$21.00M$30.00M$24.00M$0.00$32.00M$1.00M$67.00M$37.00M$2.00M
QoQ Change+320.0%-90.5%+950.0%-76.2%+200.0%+40.0%+42.9%-20.0%-100.0%-96.9%>999%-44.8%-94.6%
YoY Change+0.0%-28.6%+0.0%+100.0%+14.3%+6.7%+179.2%+15.6%-97.0%
Range$0.00$67.00M
CAGR-23.0%
Avg YoY Growth+21.1%
Median YoY Growth+6.7%
Current Streak2 quarters decline

Frequently Asked Questions

What is AbbVie's noncontrolling interest transactions and other?
AbbVie (ABBV) reported noncontrolling interest transactions and other of $2.00M in Q1 2026.
How has AbbVie's noncontrolling interest transactions and other changed year-over-year?
AbbVie's noncontrolling interest transactions and other decreased by 97.0% year-over-year, from $67.00M to $2.00M.